ARCHIVES

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

In brief: NCA Centers Subcommittee to Hammer Out New Proposals For Comprehensible Characteristics

September 28, 1979

Cancer Control Survey Determines Manpower Needs for Quality Care

July 9, 1976

New AACR Journal Avaiable Free Online Until April 15.

November 23, 2001

Clinical Trials Approved By NCI During November Are Listed

December 27, 2002

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012